Total homocysteine and cognitive decline in a community-based sample of elderly subjects: The Rotterdam study

American Journal of Epidemiology

Volumn 150, Issue 3, 1999, Pages 283-289

  Kalmijn, Sandra ^a,b,c,e   Launer, Lenore J ^a,b   Lindemans, Jan ^a   Bots, Michiel L ^d   Hofman, Albert ^a   Breteler, Monique M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c Netherlands Institute for Health Sciences   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Atherosclerosis; Cognition; Dementia; Homocysteine; Mortality; Prospective studies

Indexed keywords

HOMOCYSTINE;

ADULT; AGED; AGING; APTITUDE TEST; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CARDIOVASCULAR RISK; CLINICAL TRIAL; COGNITIVE DEFECT; CONGESTIVE CARDIOMYOPATHY; CYANOCOBALAMIN DEFICIENCY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; FOLIC ACID DEFICIENCY; FOLLOW UP; HOMOCYSTINURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NEUROTOXICITY; PREVALENCE; REGRESSION ANALYSIS; STROKE; THROMBOSIS;

EID: 0033178883     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a010000     Document Type: Article

References (42)

1. Rosenberg IH, Miller JW. Nutritional factors in physical and cognitive functions of elderly people. Am J Clin Nutr 1992; 55:1237S-43S.
2. Bots ML, Launer LJ, Lindemans J, et al. Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam Study. J Intern Med 1997;242:339-47.
3. Perry IJ, Refsum H, Morris RW, et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346:1395-8.
4. Verhoef P, Hennekens CH, Malinow MR, et al. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 1994;25:1924-30.
5. Coull BM, Malinow MR, Beamer N, et al. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke 1990;21:572-6.
6. Arnesen E, Refsum H, Bønaa KH, et al. Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995; 24:704-9.
7. Stampfer MJ, Malinow R, Willett WC, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992;268:877-81.
8. Malinow MR, Nieto FJ, Szklo M, et al. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study. Circulation 1993;87:1107-13.
9. Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotidartery stenosis. N Engl J Med 1995;332:286-91.
10. Breteler MMB, Claus JJ, Grobbee DE, et al. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ 1994;308:1604-8.
11. Hofman A, Ott A, Breteler MMB, et al. Atherosclerosis, apolipoprotein E, and the prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997;349:151-4.
12. Tatemichi TK, Desmond DW, Stern Y, et al. Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. J Neurol Neurosurg Psychiatry 1994;57:202-7.
13. Rodgers GM, Kane WH. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 1986;77:1909-16.
14. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, et al., eds. The metabolic and molecular basis of inherited disease. 7th ed. New York, NY: McGraw-Hill Book Co., 1995:1279-1327.
15. Levitt AJ, Karlinsky H. Folate, vitamin B12 and cognitive impairment in patients with Alzheimer's disease. Acta Psychiatr Scand 1992;86:301-5.
16. Sommer BR, Wolkowitz OM. RBC folic acid levels and cognitive performance in elderly patients: a preliminary report. Biol Psychiatry 1988;24:352-4.
17. Goodwin JS, Goodwin JM, Garry PJ. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 1983 ;249:2917-21.
18. Ubbink JB, van der Merwe A, Vermaak WJH, et al. Hyperhomocysteinemia and the response to vitamin supplementation. Clin Invest 1993;71:993-8.
19. Riggs KM, Spiro A III, Tucker K, et al. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 1996; 63:306-14.
20. Bell IR, Edman JS, Selhub J, et al. Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people. Acta Psychiatr Scand 1992;86:386-90.
21. Nilsson K, Gustafson L, Fäldt R, et al. Hyperhomocysteinaemia - a common finding in a psychogeriatric population. Eur J Clin Invest 1996;26:853-9.
22. Van Goor LP, Van Asselt DZB, Woiski MD, et al. Higher homocysteine levels, lower cognitive skills? Neth J Med 1998;52 (Suppl.):S7.
23. Hofman A, Grobbee DE, de Jong PTVM, et al. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991;7:403-22.
24. Ubbink JB, Vermaak WJH, van der Merwe A, et al. The effect of blood sample aging and food consumption on plasma total homocysteine levels. Clin Chim Acta 1992;207:119-28.
25. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52.
26. Ubbink JB, Vermaak WJH, Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 1991;565:441-6,
27. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-98.
28. Launer LJ. Overview of incidence studies of dementia conducted in Europe. Neuroepidemiology 1992;11 (Suppl. 1):2-13.
29. Fillenbaum GG, George LK, Blazer DG. Scoring nonresponse on the Mini-Mental State Examination. Psychol Med 1988; 18:1021-5.
30. Siu AL. Screening for dementia and investigating its causes. Ann Intern Med 1991;115:122-32.
31. Goldbohm RA, van den Brandt PA, Brants HAM, et al. Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur J Clin Nutr 1994;48:253-65.
32. Unesco. International Standard Classification of Education (ISCED). Paris, France: Unesco, 1976.
33. Final Report of the Working Group on Risk and High Blood Pressure. An epidemiological approach to describing risk associated with blood pressure levels. Hypertension 1985;7:641-51.
34. Bots ML, Hofman A, Grobbee DE. Common carotid intima-media thickness and lower extremity arterial atherosclerosis. The Rotterdam Study. Arterioscler Thromb 1994; 14:1885-91.
35. Bots ML, Hofman A, de Jong PTVM, et al. Common carotid intima-media thickness as an indicator of atherosclerosis at other sites of the carotid artery. The Rotterdam Study. Ann Epidemiol 1996;6:147-53.
36. Bots ML, Looman SJ, Koudstaal PJ, et al. Prevalence of stroke in the general population. The Rotterdam Study. Stroke 1996;27:1499-1501.
37. Boushey CJ, Beresford SAA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57.
38. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc 1992;40:922-35.
39. Belle van G, Uhlmann RF, Hughes JP, et al. Reliability of estimates of changes in mental status test performance in senile dementia of the Alzheimer type. J Clin Epidemiol 1990; 43:589-95.
40. Nunnally JC. Psychometric theory. New York, NY: McGraw-Hill Book Co., 1967:201-2.
41. Ueland PM, Refsum H, Stabler SP, et al. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-79.
42. Stehouwer CDA, Weijenberg MP, van den Berg M, et al. Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a ten year follow-up. Arterioscler Thromb Vase Biol 1998;18:1895-1901.